|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Decreasing mortality and changing patterns of causes of death in the S wiss HIV C ohort S tudy显示文摘 | R Weber M Ruppik M Rickenbach A Spoerri H Furrer M Battegay M Cavassini A Calmy E Bernasconi P Schmid M Flepp J Kowalska B Ledergerber | 2012 | HIV Med2012，，4： | 1 |
| 2 | Strong serological responses and HIV RNA increase following AS03-adjuvanted pandemic immunization in HIV-infected patients 显示文摘 | Calmy A Bel M Nguyen A | 2012 | HIV Med2012，13，4： | 1 |
| 3 | Novel surgical approach to pseudotumour of ilium in haemophilia 显示文摘 | Bellinazzo P Silvello L Calmi MT | 1989 | Lancet1989，2，8675： | 1 |
| 4 | Comparison of firstline antiretroviral therapy with regimens including nevirapine,efavirenz,or both drugs,plus stavudine and lamivudine:a randomised open-label trial,the 2NN Study显示文摘 | CALMY A PASCUAL F FORD N | 2004 | Lancet2004，363，9431： | 1 |
| 5 | HIV viral load monitoring in resource-limited regions: optional or necessary? 显示文摘 | Calmy A Ford N Hirschel B | 2007 | Clinical Infectious Diseases2007，44，1： | 1 |
| 6 | Whatt's new in HIV in 2014? 显示文摘 | Sculier D Calmy A | 2015 | Rev Med Suisse2015，11，456457： | 1 |
| 7 | The challenges of HIVHCV co-infection显示文摘 | Ambrosioni J Negro F Calmy A | 2012 | Rev Med Suisse2012，8，338： | 1 |
| 8 | Safety of efavirenz in the first trimester of pregnancy: an updated systematic review and meta-analysis显示文摘 | Ford N Calmy A Mofenson L | 2011 | AIDS2011，25，18： | 1 |
| 9 | Patient needs and point-of-care requirements for HIV load testing in resource-Iimited settings显示文摘 | Usdin M Guillerm M Calmy A | | 0，，1： | 1 |
| 10 | Safety of efavirenz in the first trimester of pregnancy: an updated systematic review and meta-analysis显示文摘 | Nathan Ford Lynne Mofenson Zara Shubber Alexandra Calmy Isabelle Andrieux-Meyer Marco Vitoria Nathan Shaffer Fran?oise Renaud | 2014 | AIDS2014，，： | 1 |
| 11 | HIV increases markers of cardiovascular risk: Results from a randomized, treatment interruption trial显示文摘 | Calmy A Gayet-Ageron A Montecucco F | 2009 | AIDS2009，23，8： | 1 |
| 12 | HIV viral load monitoring in resource-limited regions: optional or necessary7 显示文摘 | Calmy A Ford N Hirschel B | 2007 | Clin Infect Dis2007，44，1： | 1 |
| 13 | HIV increases markers of cardiovascular risk:results from a randomized,treatment interruption trial显示文摘 | CALMY A GAYET-AGERON A MONTECUCCO F | 2009 | AIDS2009，23，： | 1 |
| 14 | Generic fixed- dose combination antiretroviral treatment in resource-poor settings: multicentric observational cohort 显示文摘 | Calmy A Pinoges L Szumilin E | 2006 | AIDS2006，20，8： | 1 |
| 15 | The challenges of HIV HCV co-infection 显示文摘 | Ambrosioni J Negro F Calmy A | 2012 | Rev Med Suisse2012，8，338： | 1 |
| 16 | Adverse events associated with nevirapine and efavirenz-based first-line antiretroviral therapy:a systematic review and meta-analysis显示文摘 | Shubber Z Calmy A Andrieux-Meyer I | 2013 | AIDS2013，27，9： | 1 |
| 17 | Hepatitis B Virus Infection Is Associated With Impaired Immunological Recovery During Antiretroviral Therapy in the Swiss HIV Cohort Study显示文摘 | Gilles Wandeler Thomas Gsponer Florian Bihl Enos Bernasconi Matthias Cavassini Helen Kovari Patrick Schmid Manuel Battegay Alexandra Calmy Matthias Egger Hansjakob Furrer Andri Rauch V. Aubert J. Barth M. Battegay E. Bernasconi J. B?ni H.C. Bucher C. Burt | 2013 | Journal of Infectious Diseases2013，，9： | 1 |
| 18 | Squamous cell carcinoma of the anus-an opportunistic cancer in HIV-positive male homosexuals显示文摘Squamous cell carcinoma of the anus (SCCA) is a common cancer in the human immunodeficiency virus (HIV)infected population,and its incidence continues to increase in male homosexuals.Combined chemoradiation with mitomycin C and 5-fluorouracil was poorly tolerated by severely immunocompromised patients in the early 1990s.In the era of highly active antiretroviral therapy (HAART),however,recent data indicate that:(1) most HIV patients with anal cancer can tolerate standard chemotherapy regimens;and (2) this approach is associated with survival rates similar to those of HIV-negative patients.However,HIV-positive patients with SCCA are much younger,more likely to develop local tumor recurrence,and ultimately die from anal cancer than immune competent patients.Taken together,these findings suggest that anal cancer is an often fatal neoplasia in middle-aged HIV-positive male homosexuals.In this population,SCCA is an opportunistic disease resulting in patients with suboptimal immune function from persistent infection and prolonged exposition to oncogenic human papillomaviruses (HPVs).Large-scale cancer-prevention strategies (routine anuscopy and anal papanicolaou testing) should be implemented in this population.In addition,definitive eradication of oncogenic HPVs within the anogenital mucosa of high-risk individuals might require a proactive approach with repeated vaccination. | Pascal Gervaz Alexandra Calmy Ymer Durmishi Abdelkarim S Allal Philippe Morel | 2011 | World Journal of Gastroenterology2011，17，25： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员